Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?

Lawrence, 2008, Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II, Arthritis Rheum, 58, 26, 10.1002/art.23176 Losina, 2009, Cost-effectiveness of ACR guideline-based care and lifetime direct medical costs attributable to knee OA management in the US, 60 (S10), 1177 Bitton, 2009, The economic burden of osteoarthritis, Am J Manag Care, 15, S230 Woolf, 2003, Burden of major musculoskeletal conditions, Bull World Health Organ, 81, 646 Zhang, 2010, Epidemiology of osteoarthritis, Clin Geriatr Med, 26, 355, 10.1016/j.cger.2010.03.001 Blagojevic, 2010, Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis, Osteoarthritis Cartilage, 18, 24, 10.1016/j.joca.2009.08.010 Hunter, 2011, Lower extremity osteoarthritis management needs a paradigm shift, Br J Sports Med, 45, 283, 10.1136/bjsm.2010.081117 Hunter, 2009, How close are we to having structure-modifying drugs available?, Med Clin North Am, 93, 223, 10.1016/j.mcna.2008.07.011 Losina, 2013, Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?, Osteoarthritis Cartilage, 21, 655, 10.1016/j.joca.2013.01.016 Niu, 2009, Is obesity a risk factor for progressive radiographic knee osteoarthritis?, Arthritis Rheum, 61, 329, 10.1002/art.24337 Cooper, 2000, Risk factors for the incidence and progression of radiographic knee osteoarthritis, Arthritis Rheum, 43, 995, 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1 Wilder, 2002, History of acute knee injury and osteoarthritis of the knee: a prospective epidemiological assessment. The Clearwater Osteoarthritis Study, Osteoarthritis Cartilage, 10, 611, 10.1053/joca.2002.0795 Weinstein, 1996, Recommendations of the panel on cost-effectiveness in health and medicine, JAMA, 276, 1253, 10.1001/jama.1996.03540150055031 Holt, 2011, Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60–64 year-old US adults, Osteoarthritis Cartilage, 19, 44, 10.1016/j.joca.2010.10.009 Losina, 2011, Impact of obesity and knee osteoarthritis on Morbidity and mortality in older Americans, Ann Intern Med, 154, 217, 10.7326/0003-4819-154-4-201102150-00001 Centers for Disease Control and Prevention, 2007 Centers for Disease Control and Prevention (CDC), 2006 Centers for Disease Control and Prevention (CDC), 2008 Arias, 2010, United States life tables, 2006, vol. 58 Brazier, 1998, Deriving a preference-based single index from the UK SF-36 Health Survey, J Clin Epidemiol, 51, 1115, 10.1016/S0895-4356(98)00103-6 Diehr, 2001, Transforming self-rated health and the SF-36 scales to include death and improve interpretability, Med Care, 39, 670, 10.1097/00005650-200107000-00004 Losina, 2009, Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume, Arch Intern Med, 169, 1113, 10.1001/archinternmed.2009.136 Suter, 2013, Placing a price on medical device innovation: the example of total knee arthroplasty, PLoS One, 8, e62709, 10.1371/journal.pone.0062709 2010 Pope, 2004, Risk adjustment of Medicare capitation payments using the CMS-HCC model, Health Care Financ Rev, 25, 119 2010 2006 Losina, 2013, Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US, Arthritis Care Res (Hoboken), 65, 703, 10.1002/acr.21898 Centers for Disease Control and Prevention (CDC), 2004 Ayral, 2001, Injections in the treatment of osteoarthritis, Best Pract Res Clin Rheumatol, 15, 609, 10.1053/berh.2001.0177 Jones, 1998, Intra-articular therapies in osteoarthritis Seror, 1999, Frequency of sepsis after local corticosteroid injection (an inquiry on 1160000 injections in rheumatological private practice in France), Rheumatology (Oxford), 38, 1272, 10.1093/rheumatology/38.12.1272 Siegel, 1996, Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine, JAMA, 276, 1339, 10.1001/jama.1996.03540160061034 Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study, JAMA, 284, 1247, 10.1001/jama.284.10.1247 American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines, 2000, Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update, Arthritis Rheum, 43, 1905, 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P Zhang, 2008, OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines, Osteoarthritis Cartilage, 16, 137, 10.1016/j.joca.2007.12.013 Richmond, 2010, American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee, J Bone Joint Surg Am, 92, 990, 10.2106/JBJS.I.00982 2008 Jordan, 2003, EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), Ann Rheum Dis, 62, 1145, 10.1136/ard.2003.011742 2010 2011 Healthcare Cost and Utilization Project (HCUP), 2009 Scott, 2000, The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial, Rheumatology, 39, 1095, 10.1093/rheumatology/39.10.1095 Katz, 2007, Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older, Arthritis Rheum, 56, 568, 10.1002/art.22333 Paxton, 2010, A prospective study of 80,000 total joint and 5000 anterior cruciate ligament reconstruction procedures in a community-based registry in the United States, J Bone Joint Surg Am, 92, 117, 10.2106/JBJS.J.00807 Bensen, 1999, Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial, Mayo Clin Proc, 74, 1095, 10.4065/74.11.1095 Goldstein, 2000, Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib, J Rheumatol Suppl, 60, 25 Solomon, 2005, Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention, N Engl J Med, 352, 1071, 10.1056/NEJMoa050405 Briggs, 2012, Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–6, Value Health, 15, 835, 10.1016/j.jval.2012.04.014 Healthcare Cost and Utilization Project (HCUP), 2008 Kamath, 2003, The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis, Value Health, 6, 144, 10.1046/j.1524-4733.2003.00215.x 2011 2011 2010 2010 Braithwaite, 2008, What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?, Med Care, 46, 349, 10.1097/MLR.0b013e31815c31a7 Ubel, 2003, What is the price of life and why doesn't it increase at the rate of inflation?, Arch Intern Med, 163, 1637, 10.1001/archinte.163.14.1637 2003 Noe, 1999, The cost effectiveness of tamoxifen in the prevention of breast cancer, Am J Manag Care, 5, S389 Sanders, 2001, Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction, Ann Intern Med, 135, 870, 10.7326/0003-4819-135-10-200111200-00007 Kessler, 2008, Function, osteoarthritis and activity after ACL-rupture: 11 years follow-up results of conservative versus reconstructive treatment, Knee Surg Sports Traumatol Arthrosc, 16, 442, 10.1007/s00167-008-0498-x Louboutin, 2009, Osteoarthritis in patients with anterior cruciate ligament rupture: a review of risk factors, Knee, 16, 239, 10.1016/j.knee.2008.11.004 Palmieri-Smith, 2009, A neuromuscular mechanism of posttraumatic osteoarthritis associated with ACL injury, Exerc Sport Sci Rev, 37, 147, 10.1097/JES.0b013e3181aa6669 Messier, 2008, Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management, Rheum Dis Clin North Am, 34, 713, 10.1016/j.rdc.2008.04.007 Messier, 2013, Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial, JAMA, 310, 1263, 10.1001/jama.2013.277669 Felson, 1992, Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study, Ann Intern Med, 116, 535, 10.7326/0003-4819-116-7-535 Felson, 1998, An update on the epidemiology of knee and hip osteoarthritis with a view to prevention, Arthritis Rheum, 41, 1343, 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9 Messier, 2004, Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial, Arthritis Rheum, 50, 1501, 10.1002/art.20256 Muthuri, 2011, What if we prevent obesity? Risk reduction in knee osteoarthritis estimated through a meta-analysis of observational studies, Arthritis Care Res (Hoboken), 63, 982, 10.1002/acr.20464 Mikesky, 2006, Effects of strength training on the incidence and progression of knee osteoarthritis, Arthritis Rheum, 55, 690, 10.1002/art.22245 Riddle, 2013, Associations between statin use and changes in pain, function and structural progression: a longitudinal study of persons with knee osteoarthritis, Ann Rheum Dis, 72, 196, 10.1136/annrheumdis-2012-202159 Riddle, 2013, Response to comments in: statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study by Clockaerts et al, Ann Rheum Dis, 72, e12, 10.1136/annrheumdis-2013-203546 Clockaerts, 2012, Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study, Ann Rheum Dis, 71, 642, 10.1136/annrheumdis-2011-200092 Conaghan, 2012, The effects of statins on osteoarthritis structural progression: another glimpse of the Holy Grail?, Ann Rheum Dis, 71, 633, 10.1136/annrheumdis-2011-201135 Baker, 2011, Statins: a potential role in the management of osteoarthritis?, Joint Bone Spine, 78, 31, 10.1016/j.jbspin.2010.02.035 Kadam, 2013, Statin use and clinical osteoarthritis in the general population: a longitudinal study, J Gen Intern Med, 28, 943, 10.1007/s11606-013-2382-8 Qvist, 2010, Application of biochemical markers in development of drugs for treatment of osteoarthritis, Biomarkers, 15, 1, 10.3109/13547500903295873 Gaspoz, 2002, Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease, N Engl J Med, 346, 1800, 10.1056/NEJM200206063462309 2009, Statin cost-effectiveness in the United States for people at different vascular risk levels, Circ Cardiovasc Qual Outcomes, 2, 65, 10.1161/CIRCOUTCOMES.108.808469 Gage, 1995, Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation, JAMA, 274, 1839, 10.1001/jama.1995.03530230025025